contour+

29.5.2024

Refining Volumes – a Study on Cardiac Substructures’ Impact on Survival in Lung Cancer Patients Treated with Radiation Therapy

Cardiac diseases and cancers are leading causes of death [1]. Many cancer patients have preexistent cardiac impairment or have risk factors of developing it. On the other hand, survival after being diagnosed with cancer is increasing, so relatively more patients may develop long-term side effects. Cardiac diseases and cancers are…

Articles

21.5.2024

Time Optimisation in Radiation Therapy Planning: Insights from UK Surveys

Recently published data give a glimpse on the time spent for treatment preparation in UK radiation oncology centres. As expected,organ-at-risk and target contouring contouring is the most time-consuming step of the process. However, multiple factors influence the amplitude of this interval, and these new findings can be used as further…

Articles

19.2.2024

MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)

Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI's successful award of the tender from the Republic…

Press Releases

22.1.2024

MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland - January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL)…

Press Releases

22.1.2024

The world’s first comprehensive GBS™ solution for radiation therapy cancer treatment is now available for implementation in Canadian clinics

HELSINKI, Finland - January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+).  In conjunction with Guide and Verify, Contour+ stands as a unique solution covering all the essential needs of radiotherapy departments, offering a more comprehensive approach to staff training and patient…

Press Releases

11.1.2024

The voice of customer experience: Dr. Giuseppe Sasso, New Zealand

Dr. Giuseppe Sasso is a Radiation Oncologist with extensive experience in the field, who has been using MVision AI for more than a year already, as an individual customer. He graduated from University of Naples where he also finished residency training 25 years ago. Since then, he has treated patients…

Articles

8.1.2024

LEARN. PREVENT. SCREEN. CERVICAL CANCER CAN BECOME HISTORY.

January is Cervical Cancer Awareness Month, and these three core principles are emphasized during the 2024 campaign. Nowadays, cervical cancer is responsible for more than 300,000 deaths each year globally. Fortunately, we have the tools to prevent it, diagnose it early, and treat it efficiently in most cases. This is…

Articles

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI